Bank of New York Mellon’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-481
Closed -$23K 4730
2022
Q1
$23K Hold
481
﹤0.01% 4611
2021
Q4
$33K Buy
481
+13
+3% +$1.4K ﹤0.01% 4550
2021
Q3
$68K Buy
468
+81
+21% +$24.6K ﹤0.01% 4393
2021
Q2
$237K Buy
+387
New +$253K ﹤0.01% 4044

Other funds holding MDVL

Bank of New York Mellon's MDVL Position: Q2 2022 in Review

Bank of New York Mellon sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q2 2022, closing a stake of 481 shares — an estimated $23K sold.

Bank of New York Mellon first reported a position in MDVL in Q2 2021 and held it in 4 quarters. The position peaked at $237K in Q2 2021. 38 funds tracked by Wall St. Rank hold MDVL as of Q2 2022.

  • Bank of New York Mellon reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Bank of New York Mellon sold 481 MedAvail Holdings, Inc. Common Stock shares in Q2 2022, an estimated $23K.
  • Bank of New York Mellon first reported a position in MedAvail Holdings, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Bank of New York Mellon's MedAvail Holdings, Inc. Common Stock position peaked at $237K in Q2 2021.
  • 38 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q2 2022.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.